Utah Gov. Spencer Cox (Rep.) plans to sign a bill from his state's House and Senate that would ban adding fluoride to public ...

The Vietnam Oral Care Market, valued at USD 194.40 million in 2024, is anticipated to exhibit a CAGR of 7.18% from 2025 to 2033, reaching an estimated USD 295.37 million by the end of the forecast ...

The best toothpastes for adults have fluoride, according to dentists. Shop toothpaste with the ADA Seal of Acceptance from ...

Haleon's dividend grew 10% and is well-covered by FCF, but the 1.6% yield is less attractive compared to peers. See why I ...

Commissions do not affect our editors' opinions or evaluations. The price-to-earnings ratio, or P/E ratio, helps you compare the price of a company’s stock to the earnings the company generates.

Haleon plc (NYSE: HLN) Q4 2024 Earnings Call Transcript February 27, 2025 Haleon plc misses on earnings expectations. Reported EPS is $0.05 EPS, expectations were $25.25.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

British consumer healthcare group Haleon disappointed investors on Thursday after the Sensodyne toothpaste maker said 2025 revenue growth would be weighted to the second half of the year ...

(Reuters) -UK's Haleon reported annual profit in line with market expectations on Thursday, as the Sensodyne toothpaste and Advil painkiller maker was helped by sustained demand for its multi-vitamin ...

The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals ...

Maharashtra Cultural Affairs Minister Ashish Shelar on Tuesday announced that Freedom Fighter Vinayak Damodar Savarkar's poem 'Anadi Mi, Anant Mi' will receive the first Chhatrapati Sambhaji ...

There is no escaping from the fact that the British company has proved perennially disappointing for investors. Around £10bn has been wiped off GSK’s market value in the past year alone and shares are ...